Participants 273 317 3
patients with nasopharyngeal carcinoma (NPC)
Participants 340 510 6
A randomized controlled clinical study on rAd-p53 combined with RT in 42 patients with NPC was compared with a control group of 40 patients with NPC treated with RT alone
